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umor and viral antigens elicit a potent immune re-
sponse by heat shock protein–dependent uptake of
antigenic peptide with subsequent presentation by
MHC I. Receptors on antigen-presenting cells that speciﬁcally
bind and internalize a heat shock protein–peptide complex
have not yet been identiﬁed. Here, we show that cells
expressing CD40, a cell surface protein crucial for B cell
function and autoimmunity, speciﬁcally bind and internalize
human Hsp70 with bound peptide. Binding of Hsp70–
peptide complex to the exoplasmic domain of CD40 is
T
 
mediated by the NH
 
2
 
-terminal nucleotide–binding domain
 
of Hsp70 in its ADP state. The Hsp70 cochaperone
Hip, but not the bacterial Hsp70 homologue DnaK, com-
petes formation of the Hsp70–CD40 complex. Binding of
Hsp70-ADP to CD40 is strongly increased in the presence
of Hsp70 peptide substrate, and induces signaling via p38.
We suggest that CD40 is a cochaperone-like receptor
 
mediating the uptake of exogenous Hsp70–peptide complexes
by macrophages and dendritic cells.
 
Introduction
 
Heat shock proteins and molecular chaperones, including
Hsp70 and glucose-regulated protein 94 (Grp94),* have
been established in recent years as immune adjuvants for
cross priming with antigenic peptides (Srivastava et al.,
1994). In this process, antigen-presenting cells (APCs) inter-
nalize exogenously administered heat shock proteins with
bound peptides by receptor-mediated endocytosis (Arnold-
Schild et al., 1999), resulting in antigen presentation via
 
MHC I (Castellino et al., 2000). Tumor-bearing mice injected
with Hsp70 (or Grp94) isolated from the tumor or with a
complex of recombinant Hsp70 with bound, tumor-specific
antigenic peptide have been shown to mount a potent
CD8
 
 
 
 T cell response that can reduce or eliminate tumor
progression (Srivastava et al., 1994). However, despite intensive
research, the mechanistic details and the components in-
volved in this pathway have remained obscure.
Various cell surface proteins on immune cells are thought
to play a role in the induction of cellular responses to heat
shock proteins. One group of proteins, including the toll-
like receptors 2 and 4 with their cofactor CD14 (Asea et al.,
2002), and CD36, are reported to induce cytokine secretion
in an Hsp70-dependent manner. So far, only one surface
 
protein (CD91) has been implicated in eliciting a CD8
 
 
 
T cell response upon administration of peptide bound to
heat shock protein (Grp94; Binder et al., 2000), but an
essential role of CD91 in this process has been questioned
(Berwin et al., 2002). A recent report by Wang et al. (2001)
described a direct interaction between bacterial Hsp70
(DnaK) with CD40. However, this interaction is mediated
by the substrate-binding domain of Hsp70, making a role in
uptake of antigenic peptides unlikely.
The list of heat shock proteins and molecular chaperones
implicated as immune adjuvants includes Grp94, Hsp60,
calreticulin, and mammalian cytosolic Hsp90 and Hsp70
(Srivastava et al., 1986; Udono and Srivastava, 1993; Basu
and Srivastava, 1999; Kol et al., 2000), as well as DnaK
(Wang et al., 2001). In general, these chaperones bind to
peptide segments of nonnative polypeptides either during
synthesis or in conditions of cellular stress, preventing pro-
tein aggregation and mediating proper folding (Hartl and
Hayer-Hartl, 2002). The highly conserved members of the
Hsp70 family are the best studied among this class of com-
ponents (Bukau and Horwich, 1998). Hsp70 consists of an
NH
 
2
 
-terminal nucleotide-binding (ATPase) domain of 
 
 
 
44
kD and a COOH-terminal 25-kD domain that binds pep-
tide or polypeptide substrate. In its ATP-bound state,
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Hsp70 binds and releases peptide rapidly, whereas after hy-
drolysis, in the ADP state, bound peptide is held tightly
(Flynn et al., 1989). Hsp70 recognizes heptapeptide seg-
ments with a broad specificity but with a preference for hy-
drophobic residues, such as leucine or isoleucine (Flynn et
al., 1989; Blond-Elguindi et al., 1993; Rudiger et al., 1997).
Based on this broad range of peptides recognized, Hsp70
would be especially suited to serve as a carrier of antigenic
peptides for cross priming. Hsp70–peptide complexes may
reach the extracellular space from necrotic cells or on viral
cell lysis (Basu et al., 2000; Berwin and Nicchitta, 2001).
Various cell lines have been investigated for their ability to
bind heat shock proteins, including mostly professional
APCs such as dendritic cells (Reed and Nicchitta, 2000),
macrophages, and peripheral blood monocytes (Sonder-
mann et al., 2000).
Here, we show that binding of Hsp70 to ANA-1 macro-
phages is markedly increased after stimulation with bacte-
rial lipopolysaccharide (LPS). LPS treatment results in in-
creased expression of CD40 (Tone et al., 2001), a member
of the TNF receptor family with a crucial role in B cell
function and autoimmunity (Bodmer et al., 2002). We
find that human Hsp70 binds to the exoplasmic domain of
CD40. Interestingly, this interaction is mediated by the
NH
 
2
 
-terminal ATPase domain of human Hsp70 in its
ADP-bound state. It is strongly enhanced by the presence
of substrate peptide in the COOH-terminal domain of
Hsp70 (C70) and is inhibited by Hip, a co-chaperone
known to stabilize the Hsp70 ATPase domain in the ADP
state. These surprising mechanistic features explain why
the binding of human Hsp70 has remained undetected in a
recent report describing the interaction of the COOH-ter-
minal chaperone domain of bacterial Hsp70 (DnaK) with
CD40 (Wang et al., 2001). We show further that binding
of human Hsp70–peptide complex to cells that express
CD40 leads to peptide uptake and induction of signaling
via p38. Thus, CD40 is an extracellular receptor for pep-
tide-loaded human Hsp70 and mediates the internalization
of Hsp70-bound peptides.
 
Results
 
LPS stimulation increases expression of CD40 
and binding of Hsp70 to ANA-I macrophages
 
To determine the molecular basis for the binding of human
Hsp70 to ANA-1 cells (Sondermann et al., 2001), cells were
incubated either with biotinylated Hsp70 or with Hsp70 that
had been loaded with biotinylated peptide C (GCEVFGLG-
WRSYKH; Flynn et al., 1989) in the presence of ADP.
Bound protein was detected by fluorescence microscopy after
reaction with fluorescent streptavidin (see Materials and
methods). Unstimulated cells showed weak but clearly detect-
able binding with both Hsp70 and Hsp70–peptide complex,
whereas no binding was observed with biotin-labeled GST as
a control protein (Fig. 1 A, top). In contrast, LPS stimulation
Figure 1. LPS treatment of ANA-1 cells stimulates binding of 
Hsp70 and induces expression of CD40. Cells were incubated with 
LPS or mock-treated as outlined in Materials and methods. (A) Cells 
were incubated either with biotinylated Hsp70, Hsp70 loaded with 
biotinylated peptide C, or with biotinylated GST as a control. After 
30 min at 4 C, cells were washed, incubated with TRITC-labeled 
streptavidin, washed again, and processed for fluorescence 
microscopy. (top) mock-treated ANA-1 cells; (bottom) ANA-1 cells 
after treatment with LPS. Note that Hsp70 carries on average five 
biotins, whereas peptide C contains a single biotin. (B) Cells were 
harvested, lysed, and centrifuged to obtain a total membrane pellet. 
Identical protein amounts of the samples were analyzed by 
immunoblotting with an antibody directed against CD40. (Lanes 1 
and 4) total cell lysates; (lanes 2 and 5) membrane fractions; (lanes 
3 and 6) supernatants.
Figure 2. Transfection with human CD40 cDNA renders Cos-7 
cells active in binding human Hsp70. Cos-7 cells were transiently 
transfected with a fusion construct that contained human CD40 
cDNA, followed by an internal ribosomal entry site and the cDNA 
for EGFP, giving rise to green fluorescence of transfected cells. Cells 
were incubated for 30 min at 0 C with biotinylated Hsp70 (A), 
biotinylated GST as a control (B), Hsp70–peptide complex containing 
biotinylated peptide C (C), or with biotinylated peptide C alone (D). 
Thereafter, cells were washed and incubated with TRITC-streptavidin 
and processed for fluorescence microscopy as described in Fig. 1. 
Left-hand panels show streptavidin fluorescence and right-hand 
panels show EGFP fluorescence. 
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resulted in a significant increase in binding of Hsp70 and
Hsp70 peptide, but not of GST (Fig. 1 A, bottom).
Mock-treated and LPS-stimulated ANA-1 cells were an-
alyzed for their expression of CD40. As shown in Fig. 1 B,
LPS-stimulated cells, but not control cells, express high
levels of membrane-bound CD40, as detected by immuno-
blotting (Tone et al., 2001). To assess the possibility that
CD40 itself may serve as an Hsp70 receptor, Cos-7 cells,
which do not express CD40, were transfected with a
cDNA construct containing the cDNA for human CD40,
followed by an internal ribosomal entry site and the cDNA
for EGFP. Transfected cells were identified by virtue of
their GFP fluorescence, and were analyzed for their ability
to bind biotin-labeled Hsp70 or Hsp70–biotin–peptide
complex (Fig. 2). Indeed, Hsp70 and its peptide complex
bound to the surface of transfected cells, but not to un-
transfected cells, whereas no binding above background
was detected with biotinylated GST or biotinylated pep-
tide alone (Fig. 2).
Binding experiments were performed in vitro to deter-
mine whether CD40 and Hsp70 interact directly. To this
end, the exoplasmic domain of human CD40 (aa residues
20–212) was expressed in 
 
Escherichia coli
 
 as a soluble GST-
fusion protein and used to study its interaction with heat
shock proteins in HeLa cell lysates. Increasing amounts
of GST-CD40 were incubated with the lysates and
bound proteins were adsorbed to glutathione-Sepharose,
followed by immunoblotting with antibodies directed
against Hsc70, Hsp70, and Hsp90. As shown in Fig. 3 A,
Hsc70 and Hsp70 bound to GST-CD40 in a concentra-
tion-dependent manner, whereas Hsp90 did not interact.
As will be shown later, the interaction of Hsp70 with
CD40 is enhanced in the presence of ADP. GST alone,
used as a negative control, did not bind Hsc70/Hsp70.
These experiments demonstrate a direct and specific inter-
action of CD40 with mammalian Hsp70s.
 
Human Hsp70 binds to CD40 via its ATPase domain
 
Next, we investigated the biochemical requirements for
CD40–Hsp70 complex formation. Specifically, we ad-
dressed the question whether Hsp70 binds to CD40 via its
COOH-terminal substrate-binding domain or via its NH
 
2
 
-
terminal nucleotide-binding domain. In this context, it was
of interest whether the association depended on a specific
nucleotide-bound state of Hsp70. Recombinant Hsp70 was
incubated with GST-CD40 in the presence of ADP or ATP,
with or without substrate peptide (Fig. 3 B). Hsp70 binding
to CD40 was barely detectable in the presence of ATP, and
was only seen in the presence of ADP. Notably, addition of
a molar excess of peptide C over Hsp70 did not compete
with the interaction, as might have been expected if the
COOH-terminal Hsp70 domain were to mediate binding of
Hsp70 to CD40. Only background signals were observed
when GST alone was analyzed as a control. Recombinant,
His-tagged Hsp70 also interacted, in an ADP-dependent
manner, with endogenous CD40 in extracts of LPS-stimu-
lated ANA-1 cells, as detected by adsorption of the complex
to Ni-NTA agarose and immunoblotting with CD40 anti-
body (Fig. 3 C). Together, these results suggested that
Hsp70 binds to CD40 via its ATPase domain.
In light of recent findings that the bacterial Hsp70 homo-
logue DnaK associates with CD40 via the COOH-terminal
peptide–binding domain (Wang et al., 2001), experiments
were performed to directly determine the specificity of
CD40 for the domains of human Hsp70. Recombinant,
full-length Hsp70 was incubated in the presence of ADP and
a fivefold molar excess of either recombinant Hsp70 NH
 
2
 
-
terminal domain (residues 1–381; Sondermann et al., 2001)
or COOH-terminal domain (residues 382–641; Scheufler et
al., 2000), or of recombinant, full-length DnaK. The NH
 
2
 
-
terminal domain of Hsp70 (N70) efficiently competed for
the binding of full-length Hsp70 to CD40, as detected with
an antibody against the NH
 
2
 
-terminal His6 tag on recombi-
Figure 3. Binding of Hsp70 to CD40 is direct and 
depends on ADP. (A) HeLa cell lysates were incubated 
with GST (control) or GST-CD40 in the amounts indicated. 
Thereafter, samples were affinity-purified on glutathione-
sepharose as outlined in Materials and methods, subjected 
to SDS-PAGE, and analyzed by immunoblotting with 
antibodies directed against Hsc70 and Hsp70 (top lanes), 
and against Hsp90 (bottom lanes). (B) Human recombinant 
His6-tagged Hsp70 was incubated with ATP, ADP, or an 
excess of peptide C, followed by addition of CD40-GST 
or GST alone. After affinity purification, samples were 
analyzed by immunoblotting as described in A, using 
antibodies directed against the His6 tag. (C) Recombinant 
human His6-tagged Hsp70 was incubated with peptide C, 
either in the presence or absence of ADP. The reactions 
were then incubated with ANA-1 cell lysates as described 
in Materials and methods. Protein bound to Hsp70 was 
analyzed by affinity purification on Ni-NTA agarose 
and immunoblotting with antibodies directed against 
CD40. Input reflects the amount of protein subjected 
to affinity purification. 
1280 The Journal of Cell Biology 
 
|
 
 
 
Volume 158, Number 7, 2002
 
nant Hsp70 (Fig. 4 A). The ATPase domain itself bound to
CD40 in the presence of ADP but not ATP (Fig. 4 C). In
contrast, neither the COOH-terminal Hsp70 domain (C70)
nor DnaK had a significant effect on this binding (Fig. 4 A).
To analyze whether under these conditions DnaK binds di-
rectly to CD40, a pulldown experiment was performed with
DnaK. As shown in Fig. 4 B, DnaK indeed binds to CD40,
and this interaction is enhanced in the presence of ADP
when compared with ATP. This establishes that Hsp70 and
DnaK bind to different sites on CD40, and confirms that
DnaK binds via its COOH-terminal domain as reported ear-
lier (Wang et al., 2001). This binding strongly suggested
that it is the substrate-binding site of DnaK that mediates
the interaction with CD40. To address this possibility, a
competition experiment was performed with an excess of
peptide C. As shown in Fig. 4 B, a 10-fold molar excess of
the peptide almost completely abolishes the binding of
DnaK to CD40. Thus, it is the substrate binding of DnaK
that interacts with CD40. In summary, Hsp70 interacts with
CD40 dependent on ADP, and via its ATPase domain, as
shown with the endogenous proteins in cell extracts and the
recombinant proteins in vitro. In contrast, DnaK binds to
CD40 via its substrate binding site proper.
 
Hsp70 binding to CD40 is competed by the Hsp70 
cochaperone Hip, and is enhanced by peptide substrate
 
N70 is known to specifically interact with the regulatory co-
chaperone proteins Hip and Bag-1. Although Hip stabilizes
the ADP state of Hsp70, which binds substrate tightly
(Höhfeld et al., 1995), Bag-1 functions as an ADP–ATP ex-
change factor and causes substrate release from Hsp70
(Höhfeld and Jentsch, 1997; Sondermann et al., 2001). In
light of the observed ADP dependence, it seemed possible
that CD40 binding to Hsp70 has certain features in com-
mon with the interaction between Hip and Hsp70. Binding
of Hsp70 to CD40 was analyzed in the presence of a fivefold
molar excess of recombinant Hip or Bag-1 over Hsp70 (Fig.
4 D). Hip acted as an effective competitor of the interaction,
in contrast to Bag-1, which interacts only relatively weakly
Figure 4. Hsp70 binding to CD40 is mediated by the NH2-terminal 
ATPase domain and is competed by Hip. (A) Human His6-tagged 
Hsp70, its NH2- or COOH-terminal domains, or recombinant 
bacterial DnaK was incubated either with GST-CD40 or with GST. 
(B) Recombinant DnaK was incubated with ADP, ATP, or an excess 
of peptide C, followed by addition of GST-CD40 or GST alone. 
(C) His6-tagged N70 was incubated in the presence of ADP or ATP, 
followed by incubation with a 10-fold molar excess of Hsp70 in the 
presence of ADP or ATP. (D) Recombinant human His6-tagged 
Hsp70 protein was incubated with a fivefold molar excess of either 
recombinant Hip protein or Bag-1, and with GST-CD40 or GST 
as a control. Bound protein was analyzed after affinity purification 
on glutathione-sepharose by immunoblotting with an antibody 
directed against the NH2-terminal His6 tags, or with an antibody 
directed against DnaK.
Figure 5. Peptide substrate stimulates Hsp70 binding to CD40. 
(A) His6-tagged Hsp70 was incubated with increasing concentrations 
of peptide C as indicated, and binding to GST-CD40 was analyzed 
by immunoblotting with antibodies directed against the His6-tag. 
The bottom panel is a quantitation of the data. (B) Equivalent 
concentrations (3  M) of His6-tagged Hsp70 (in the presence of 2 
mol ADP and in the absence or presence of a 30-fold molar excess 
of peptide C) or His6-tagged N70 were incubated with GST-CD40, 
and bound protein was analyzed as described for panel A.  
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with the ADP state of Hsp70 (Höhfeld, 1998; Sondermann
et al., 2001). Thus, CD40 and Hip may share similar bind-
ing regions on the ATPase domain of Hsp70.
The known cochaperone function of Hip in stabilizing
Hsp70 in its substrate-bound ADP state (Höhfeld et al.,
1995) raised the interesting possibility that the interaction
between CD40 and Hsp70 may not only be ADP-regulated,
but may also depend on Hsp70 substrate. Strikingly, bind-
ing of Hsp70-ADP to CD40 increased dramatically in the
presence of peptide C (Fig. 5, A and B). The effect of pep-
tide was saturable (k
 
a
 
 
 
  
 
30 
 
 
 
M) in a range corresponding to
the affinity of peptide C for Hsp70 (5–10 
 
 
 
M; Greene et
al., 1995). These results demonstrate that it is the peptide-
and ADP-bound state of Hsp70 that is recognized preferen-
tially by CD40 and suggest that, similar to Hip, CD40 has a
regulatory function in stabilizing the Hsp70–substrate com-
plex. This effect would ensure that CD40 binds Hsp70 pre-
dominantly when it is in complex with peptide.
The striking increase in CD40 binding of ADP-loaded
Hsp70 observed in the presence of peptide substrate raised
the question of whether the free C70 has an inhibitory effect
on the ATPase domain, reducing the ability of the latter to
recognize CD40. This possibility was addressed by compar-
ing the binding efficiency of substrate-saturated Hsp70 to
that of the NH
 
2
 
-terminal domain, both in their ADP states.
As shown in Fig. 5 C, substrate-loaded Hsp70 and the NH
 
2
 
-
terminal domain bound to CD40 with similar efficiencies,
indicating that the peptide-free C70 masks the NH
 
2
 
-domain
for binding to CD40, either directly or by causing an allo-
steric conformational change.
 
Binding of Hsp70–peptide complex to CD40 results in 
intracellular signaling and peptide uptake
 
Binding of CD40 ligand to CD40 induces signal transduc-
tion via phosphorylation of p38, a component of the signal
cascade between activated CD40 and NF
 
 
 
B, which eventu-
ally results in the release of TNF
 
 
 
 and subsequent secretion
of interferon-
 
 
 
 (Pullen et al., 1999). Binding of the COOH-
terminal domain of DnaK to CD40 was reported to have a
similar effect (Wang et al., 2001). Therefore, we investigated
whether binding of human Hsp70–peptide complex to
CD40 also stimulates this signaling pathway. These experi-
ments were performed in HEK293T cells stably transfected
with human CD40 cDNA. After incubation with either
Hsp70–peptide complex, recombinant Hsp70 domains, or
DnaK, in the presence of ADP or the nonhydrolysable ATP
analogue AMPPNP, cells were lysed and lysates were ana-
lyzed by immunoblotting with an antibody directed against
active (i.e., phosphorylated) p38. Indeed, human Hsp70
and its ATPase domain caused an increase in phosphory-
lated p38 to an extent comparable to that observed with
DnaK (Fig. 6 A, top panel). Although modest when com-
pared with the signal induced by the same molar concentra-
tion of CD40 ligand, activation of p38 by Hsp70 was signif-
icant, and depended on the presence of ADP. As a control,
HEK293T cells stably transfected with the same vector, but
containing the cDNA for an unrelated membrane protein,
murine cationic amino acid transporter (MCAT), did not
show a detectable response to the various stimuli (Fig. 6 A,
bottom panel). Thus, Hsp70–peptide complex and the
Hsp70 ATPase domain activate signaling via CD40, depen-
dent on the presence of ADP and in a manner comparable
to the effect of DnaK, although the latter binds to CD40 via
its COOH-terminal domain (Wang et al., 2001).
Next, we examined whether binding of Hsp70–peptide
complex to CD40 results in the uptake of peptide. To this
end, HEK293T-CD40 cells and HE293T-MCAT cells (not
expressing CD40) were incubated with a fluorescent (FITC)
derivative of peptide C for 30 min at 0
 
 
 
C in the presence of
ADP, with or without Hsp70 or its two domains. After re-
moval of excess material, the cells were incubated at 37
 
 
 
C
for 15 min, fixed, and then analyzed by fluorescence micros-
copy. Representative images are presented in Fig. 6 B. After
Figure 6. Binding of Hsp70 complex to CD40-expressing 
HEK293T cells induces signaling via p38 and causes peptide uptake. 
(A) HEK293T cells, stably transfected with cDNA encoding human 
CD40 or the unrelated membrane protein (MCAT) were incubated 
for 20 min at 37 C with CD40L or with Hsp70, N70, C70, or 
bacterial DnaK in the presence of peptide C and ADP or AMPPNP, 
or buffer alone. Thereafter, cells were washed, solubilized in SDS-
sample buffer, and analyzed by immunoblotting with antibodies 
directed against phosphorylated (active) p38. Blots were also 
developed with an antibody against tubulin in order to control for 
equal loading. (B) Cells were incubated at 0 C for 30 min with 
recombinant human Hsp70, N70, or C70, all in the presence FITC-
labeled peptide, or with the FITC-labeled peptide alone. Thereafter, 
cells were washed, incubated for 15 min at 37 C, and processed 
for fluorescence microscopy. (1) Hsp70, (2) FITC-labeled peptide 
alone, (3) C70, and (4) N70. Only cells stably transfected with 
CD40 are shown. Cell boundaries are emphasized with broken 
lines. MCAT-expressing control cells did not show fluorescence 
above background. 
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15-min incubation at 37
 
 
 
C, fluorescent peptide was ob-
served in punctuate intracellular structures only in cells ex-
pressing CD40, and only when Hsp70 was present during
the incubation for binding at 0
 
 
 
C (Fig. 6 B, panel 1).
No staining above background was detected when Hsp70
was omitted (Fig. 6 B, panel 2). Likewise, incubation of
HEK293T-CD40 cells with either recombinant C70 or
N70 and peptide did not result in a peptide signal above
background (Fig. 6 B, panels 3 and 4). HEK293T-MCAT
control cells did not give rise to a signal under any of the
conditions tested (unpublished data). We conclude that the
specific interaction of CD40 with Hsp70–peptide complex
mediates the uptake of peptide.
 
Discussion
 
Our results establish the cell surface protein CD40 as a re-
ceptor for exogenously added human Hsp70–peptide
complexes. The functional properties of the CD40–Hsp70
interaction ensure surface binding and uptake of Hsp70-
associated peptide (Fig. 7). Binding to CD40 is mediated by
the ATPase domain of Hsp70, and depends critically on the
ADP-loaded state of the chaperone, which binds peptide
tightly. Moreover, complex formation between CD40 and
Hsp70 is strongly enhanced by the presence of Hsp70 pep-
tide substrate. We suggest that the CD40–Hsp70 interac-
tion shares important functional features with the interac-
tion between Hsp70 and certain intracellular cochaperones,
such as Hip.
Although a variety of cell surface proteins have been re-
ported to stimulate the immune system upon binding of
molecular chaperones in model cell systems (Introduction),
only in the case of CD40 has such an interaction been estab-
lished directly. Wang et al. (2001) have shown recently that
the bacterial homologue of mammalian Hsp70 (DnaK) is
able to bind to HEK293T cells transfected with CD40
cDNA, and can be coimmunoprecipitated with CD40 from
monocytic THP1 cells. However, this interaction is medi-
ated by the COOH-terminal substrate-binding domain of
DnaK, as opposed to the ATPase domain. In fact, Wang et
al. (2001) concluded that human Hsp70 does not bind to
CD40, apparently because binding was examined in the ab-
sence of nucleotide and peptide substrate. Our observations
are fully consistent with those of Wang et al. (2001), as we
find that human Hsp70 and DnaK both bind to indepen-
dent sites on CD40. Nevertheless, both chaperones are able
to elicit signaling via the CD40 receptor to a similar extent.
This signaling is an established function of the interaction of
CD40 with CD40 ligand, which induces a signal transduc-
tion cascade that activates NF
 
 
 
B, leads to secretion of
TNF
 
 
 
 and interferon-
 
 
 
, and involves uptake of the recep-
tor–ligand complex (Manning et al., 2002). The presence of
a dileucine motif in the cytoplasmic domain of CD40 sug-
gests a mechanism of uptake by endocytosis via the adaptor/
clathrin system (Kirchhausen et al., 1997). Thus, in contrast
to bacterial DnaK, binding of human Hsp70 has a dual role.
In addition to stimulating activation of p38, human Hsp70
mediates the uptake of peptide bound to its substrate-bind-
ing domain. Evidently, this latter function cannot be served
by DnaK, considering that its substrate-binding site is occu-
pied by CD40. The less pronounced dependence on ADP of
DnaK binding to CD40 may be explained by the fact that
DnaK has a higher intrinsic ATPase activity than Hsp70,
generating ADP-bound DnaK in the incubation.
Clearly, the most remarkable feature of Hsp70 binding to
CD40 is the dramatic dependence of the interaction on sub-
strate peptide bound to C70. Our results suggest that CD40
interacts exclusively with the ATPase domain of Hsp70, in
the presence of ADP. Thus, the free COOH-terminal do-
main apparently masks the ATPase domain, either directly
or by an allosteric conformational change, preventing recog-
nition by CD40. This inhibitory effect is released when pep-
tide is bound (Fig. 5, A and B). Conversely, it follows that
CD40 stabilizes the ATPase domain in the ADP state that
holds bound peptide stably. A similar effect in stabilizing
Hsp70 in the ADP state has previously been described for
the Hsp70 cochaperone Hip (Höhfeld et al., 1995). Indeed,
binding of Hip to the ATPase domain of Hsp70 blocks the
Figure 7. Model for the release of 
Hsp70–peptide complex from a 
necrotic tumor cell, followed by 
binding and uptake by an APC. (1) Ne-
crosis leads to cell swelling and a 
concomitant drop in the concentration 
ratio of ATP/ADP. Intracellular Hsp70 
is bound to unfolded protein or peptide. 
(2) Release of Hsp70–peptide complexes 
upon cell lysis. At the low nucleotide 
concentrations prevailing in the extra-
cellular space, the half-life of the Hsp70-
ADP state determines the stability of the 
Hsp70–peptide complex. (3) Hsp70–
peptide complex binds to the surface of 
an APC. (4) Cell surface binding is 
mediated by the extracytoplasmic 
domain of CD40. (5) Hsp70-peptide 
binding alters the trimeric structure of 
CD40 (Chan et al., 2000), followed by 
activation of signaling via p38. (6), 
Hsp70–peptide complex is internalized 
by receptor-mediated endocytosis. 
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interaction of Hsp70 with CD40, suggesting that Hip and
CD40 recognize overlapping regions on the ATPase domain.
The functional features of the CD40–Hsp70 interaction
may be adapted to a role in the uptake of Hsp70–peptide
complexes into APCs for cross priming. Fig. 7 describes a
model for the binding of peptide antigen to Hsp70 in a tu-
mor cell, followed by release after necrotic cell lysis and
CD40-mediated uptake of the Hsp70–peptide complex by
an APC. Peptide binding to Hsp70 would be facilitated by
the high intracellular concentration of ATP and the activ-
ity of the Hsp70 cochaperone Hsp40 in catalyzing peptide
loading (Minami and Minami, 1999). During cell necro-
sis, the internal concentration of ATP relative to ADP
drops markedly (Bradbury et al., 2000). A further dilution
of ATP (and of Hsp70 cochaperones) would occur upon
lysis and release of cytosol content into the extracellular
medium. As a result, peptide-bound Hsp70 remains in its
ADP state, the stability of which determines the half-life of
the Hsp70–peptide complex. Importantly, although pep-
tide loading onto Hsp70 is possible in the absence of nu-
cleotide with low efficiency (Minami et al., 1996), low nu-
cleotide concentration would prohibit the reformation of
an Hsp70–ADP–peptide complex in the extracellular
space. Thus, the strong preference of CD40 for Hsp70–
ADP–peptide ensures not only the binding of peptide-
loaded Hsp70, but would also guarantee that intracellular
peptide antigen is made available for cross priming. Thus,
the uptake of circulating extracellular peptides, potentially
triggering autoimmune reactions, would be avoided. Fu-
ture work will be directed toward testing this model, with a
focus on the fate of Hsp70-bound peptide after uptake
into APCs, including possible peptide representation on
the cell surface via MHC I.
 
Materials and methods
 
Plasmids and protein preparation
 
Human Hsp70, N70 and C70, Hip, and Bag-1 were expressed and purified
as His-tagged proteins (Höhfeld et al., 1995; Scheufler et al., 2000; Son-
dermann et al., 2000, 2001). DnaK was expressed as described previously
(Szabo et al., 1994). After ATP-sepharose affinity chromatography as de-
scribed previously (Sondermann et al., 2000) Hsp70, N70, and DnaK were
extensively dialyzed (twice against a 200-fold volume of PBS) in order to
obtain essentially nucleotide-free proteins. Equine GST was purchased
from Sigma-Aldrich. Biotinylated recombinant Hsp70 and equine GST
were prepared by labeling with the FluoReporter
 
®
 
 Biotin-XX Protein Label-
ing Kit (Molecular Probes, Inc.). Human CD40 cDNA was amplified by
PCR from a human primary macrophage cDNA library (Invitrogen), and in-
serted into pcDNA3.1/Zeo and pIRES2-EGFP vector (Invitrogen). The
cDNA for the exoplasmic domain of CD40 (aa 20–212) was amplified by
PCR from the human CD40 cDNA described above, and inserted into
pGEX-2T vector (Amersham Biosciences). GST and GST-CD40 fusion pro-
tein was purified by glutathione affinity chromatography (Glutathione
Sepharose 4 Fast Flow; Amersham Biosciences). Peptide C (GCEVFGLG-
WRSYKH), biotinylated peptide C (biotin-GCEVFGLGWRSYKH), and pep-
tide C-FITC (FITC-GCEVFGLGWRSYKH) were custom synthesized by R.
Piepkorn (Deutsches Krebsforschungs Zentrum, Heidelberg).
For Hsp70–peptide complex formation, Hsp70 was incubated with a
fivefold excess of peptide C, biotinylated peptide C, or peptide C-FITC for
30 min at 37
 
 
 
C in binding buffer consisting of the following (mM): 10
MOPS-KOH, pH 7.2, 150 KCl, 2 ADP, and 3 MgCl
 
2
 
. Excess of unbound
peptide C–biotin was removed by gel filtration on Sephadex G-50 (Amer-
sham Biosciences). Quantification of Hsp70 complex formation by ELISA
using a streptavidin–peroxidase conjugate (Molecular Probes, Inc.) indi-
cated yields of 20–30%. All proteins were centrifuged at 100,000 
 
g
 
 at 4
 
 
 
C
for 1 h before the experiments in order to remove aggregates.
 
Cell culture and fluorescence microscopy
 
The murine macrophage cell line ANA-11 was provided by H. Wagner
(Technische Universität München, Munich, Germany). ANA-1 cells were
cultured in VLE-RPMI 1640 (Biochrom Ltd.), supplemented with 10% FCS,
2 mM 
 
L
 
-glutamine, and antibiotics. For fluorescence microscopy, ANA-1
cells were either stimulated with LPS (20 
 
 
 
g/ml; Sigma-Aldrich), or kept in
an LPS-free medium (mock treatment) for 7 h. After stimulation, cells were
harvested and incubated with 100 nM biotinylated Hsp70, biotinylated
GST, or Hsp70–peptide C–biotin complex for 30 min at 0
 
 
 
C in VLE-RPMI
1640. After incubation, cells were processed for staining with streptavidin-
TRITC (Sigma-Aldrich), fixed with PFA, and analyzed by fluorescence
microscopy (Axiovert 35; Carl Zeiss MicroImaging, Inc.) as described pre-
viously (Sondermann et al., 2000). Cos-7 cells were cultured in DME sup-
plemented with 10% FCS, 2 mM 
 
L
 
-glutamine, and antibiotics (Biochrom
Ltd.), grown on coverslips in 24-well plates, and transiently transfected
with human CD40 cDNA (inserted into the pIRES2-EGFP vector; Invitro-
gen) by the calcium phosphate method (Chen and Okayama, 1987). 24 h
after transfection, cells were incubated with 250 nM biotinylated Hsp70,
biotinylated GST, or Hsp70–peptide C–biotin complex for 30 min at 0
 
 
 
C in
DME, fixed, stained with streptavidin-TRITC, and analyzed by fluorescence
microscopy as described previously (Sondermann et al., 2000). HEK293T
cells were grown on collagen-coated dishes or coverslips, and cultured in
DME supplemented with 10% FCS, 2 mM 
 
L
 
-glutamine, and antibiotics.
HEK293T cells were stably transfected (Chen and Okayama, 1987) with
CD40 cDNA cloned into pcDNA3.1/Zeo (Invitrogen), and selected with
Zeocin™ (Invitrogen). Stably transfected cell lines were analyzed by im-
munoblotting for CD40 expression using an anti-CD40 antibody (CSA180;
StressGen Biotechnologies). HEK293T-MCAT cells expressing the MCAT
cloned into pcDNA3.1/Zeo vector were provided by W. Nickel (Bio-
chemie Zentrum Heidelberg, Heidelberg, Germany). S-HeLa cells were
cultured in 
 
 
 
-MEM supplemented with 8% FCS, 
 
L
 
-glutamine, and antibiot-
ics, and grown in spinner flasks.
For experiments to study uptake of the Hsp70–peptide C–FITC complex,
HEK293T-CD40 and HEK293T-MCAT cells were seeded on collagen-
coated coverslips 24 h before the experiment. For complex formation
Hsp70, N70, or C70 were preincubated with a 10-fold molar excess of
peptide C-FITC for 30 min at 37
 
 
 
C, as described above for the biotinylated
proteins. HEK293T-CD40 and HEK293T-MCAT were incubated with 0.5
 
 
 
M of Hsp70, N70, or C70, and preincubated with 2 mM ADP and 5 
 
 
 
M
peptide C-FITC, or 5 
 
 
 
M peptide C-FITC alone for 30 min on ice. Thereaf-
ter, the cells were washed three times with medium, incubated for 15 min
at 37
 
 
 
C, fixed, embedded in Fluoromount-G, and analyzed by confocal
microscopy (LSM 510; Carl Zeiss MicroImaging, Inc.).
 
Analysis of CD40 expression
 
For immunoblot analysis, ANA-1 cells were stimulated with LPS or mock
treated as described under Cell culture and fluorescence microscopy, har-
vested, lysed by repeated passage through a needle (0.4–0.8 mm; Braun) in
the presence of protease inhibitors (complete, EDTA free; Roche), and frac-
tionated by centrifugation at 100,000 
 
g
 
 at 4
 
 
 
C for 1 h. The pellet was resus-
pended in 0.1% Triton X-100/PBS, and protein concentrations were deter-
mined in total lysate; supernatant and pellet fractions were determined by
the Bradford assay (Bio-Rad Laboratories). Equal amounts of protein were
subjected to SDS-PAGE, and were analyzed by immunoblotting with an
anti-CD40 antibody (CSA180; StressGen Biotechnologies).
 
Binding assays with GST-CD40
 
For binding of endogenous Hsp70 and Hsc70 from HeLa cell lysate, HeLa
cells were lysed as described above and centrifuged at 100,000 
 
g
 
 at 4
 
 
 
C
for 1 h. 20-
 
 
 
l bed volume of Glutathione Sepharose 4 Fast Flow (Amer-
sham Biosciences) per sample was preincubated with 80 or 400 pmol of
GST or GST–CD40 fusion protein in 50 
 
 
 
l binding buffer. Unbound pro-
tein was removed by washing three times with PBS. The beads were
treated with 1% BSA-PBS to avoid nonspecific binding, and then incu-
bated with 150 
 
 
 
l of HeLa cell lysate in the presence of 2 mM DTT for 20
min at 16
 
 
 
C. The immobilized proteins were washed three times with 1 ml
PBS and eluted with 20 
 
 
 
l elution buffer (50 mM Tris-HCl, pH 8.0, 10 mM
reduced glutathione) for 10 min at 37
 
 
 
C. 10 
 
 
 
l of the eluates was subjected
to SDS-PAGE and analyzed by immunoblotting using an anti-Hsc/Hsp70
antibody and an anti-Hsp90 antibody (SPA822 and SPA835; StressGen
Biotechnologies).
For binding assays with recombinant His
 
6
 
-tagged Hsp70 and its His
 
6
 
-
tagged domains or DnaK, 2.8 
 
 
 
M of each protein was incubated with 2
mM ATP, 2 mM ADP, or 2 mM ADP and 28 
 
 
 
M peptide C in 50 
 
 
 
l bind-
ing buffer consisting of the following (mM): 10 MOPS-KOH, pH 7.2, 150
KCl, and 3 MgCl
 
2
 
 for 30 min at 37
 
 
 
C. In competition experiments, binding 
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was probed with either a 10-fold excess of Hsp70, the two domains,
DnaK, or with a fivefold excess of Hip or Bag-1 for 10 min at 0
 
 
 
C. To this
end, Hsp70, N70, C70, and DnaK were preincubated with ADP, ATP, and
peptide C as described under Plasmids and protein preparation. For com-
parison of CD40 binding of Hsp70 and its NH
 
2
 
-terminal domain, Hsp70
was preincubated in the presence or absence (mock treatment) of a 30-fold
molar excess of peptide C. 3 
 
 
 
M GST or GST-CD40 was added to the sam-
ples and incubated for 20 min at 16
 
 
 
C. For titration of peptide C, 5–50-fold
excess of peptide C (15–150 
 
 
 
M) was added to the preincubation of
Hsp70. Thereafter, the samples were combined with 20 
 
 
 
l of 1% BSA-
treated Glutathione Sepharose 4 Fast Flow and incubated in the presence
of 2 mM DTT for another 20 min at 16
 
 
 
C. Unbound proteins were re-
moved by washing the beads three times with 1 ml PBS, and immobilized
proteins were eluted with 30 
 
 
 
l elution buffer for 20 min at 22
 
 
 
C. 10 
 
 
 
l of
the eluates were subjected to SDS-PAGE and analyzed by immunoblotting
using a Penta-His antibody (QIAGEN). Blot signals were quantified by
Quantity One software (Bio-Rad Laboratories).
Binding assay with His6-tagged Hsp70 and Ni-NTA agarose
ANA-1 cells were stimulated with LPS as described above and lysed in ly-
sis buffer (150 mM Tris-HCl, pH 7.5, 1% CHAPS) for 45 min at 4 C. Cell
lysate was centrifuged at 100,000 g for 15 min at 4 C. 500  l of the super-
natant was incubated with 10  g His6-tagged Hsp70, preincubated with
ADP and a 30-fold excess of peptide C, or mock-treated, as described
above for biotinylated proteins, for 30 min at 4 C. Thereafter, the samples
were added to 20  l of 1% BSA-treated Ni-NTA agarose (QIAGEN) and in-
cubated for 30 min at 4 C. Unbound protein was removed by washing the
beads three times with 1 ml lysis buffer, and immobilized proteins were
eluted with 10  l SDS-PAGE–sample buffer by incubation for 5 min at
95 C. Eluates were analyzed by immunoblotting using an anti-CD40 anti-
body (CSA-180; StressGen Biotechnologies).
p38 kinase assay
24 h before p38 kinase assays, HEK293T-CD40 and HEK293T-MCAT
cells were seeded into a 24-well plate coated with collagen and incu-
bated with 100 nM CD40L (Alexis Biochemicals Corp.), HSP70, N70-
domain, C70-domain, or DnaK for 20 min at 37 C. DnaK, Hsp70, N70,
and C70 were preincubated with either 2 mM ADP and 30  M peptide C
or 40  M AMPPNP (Sigma-Aldrich). On stimulation, cells were washed
twice with ice-cold PBS and lysed in SDS–sample buffer. Equal amounts
of protein were analyzed by immunoblotting with antibodies directed
against phosphorylated p38 (Promega), and with a monoclonal antitubu-
lin antibody (J. Wehland, German Research Centre for Biotechnology,
Braunschweig, Germany).
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